From Louisiana to Long Island, hyperbaric chambers, once used only to treat divers suffering from the bends, are increasingly being used to treat COVID-19 patients with surprising success.
While the numbers are small, doctors at more than a dozen hospitals across the country say hyperbaric oxygen therapy (HBOT) is saving the lives of even the most critically ill coronavirus patients.
"The results thus far are pretty impressive," Dr. Thomas Serena, founder and director of the SerenaGroup, a family of wound, hyperbaric and research companies, said in a recent interview.
At NYU Winthrop Hospital in Mineola, New York, Dr. Scott Gorenstein, the director of hyperbaric medicine, said, "I'm encouraged that hyperbaric oxygen could be a benefit."
[...] Their study compared 20 COVID-19 patients who received HBOT to 60 similar patients who did not. While their study is being peer-reviewed and has yet to be published, the results they shared are stunning.
Of the 60 patients who did NOT receive HBOT, half of them needed to be placed on ventilators and 13 died. That's a mortality rate of 22%. At the same time, the 20 patients who did receive HBOT, only two needed to be placed on ventilators and both died, which is a much lower mortality rate of 10%.
"It's small numbers," Dr. Lee noted in a cautious tone but added, "The findings suggest that hyperbaric oxygen could reduce the mortality of this disease by half."
(Score: 2) by ChrisMaple on Tuesday July 28 2020, @12:44AM (1 child)
What was the pressure in the hyperbaric chamber? What was the partial pressure of oxygen? What inert gas was used, or were they just using compressed air?
Could a high oxygen environment at STP have been as useful as a hyperbaric chamber?
(Score: 0) by Anonymous Coward on Tuesday July 28 2020, @04:11AM
Probably similar to these studies: https://soylentnews.org/comments.pl?noupdate=1&sid=38685&page=1&cid=1027103#commentwrap [soylentnews.org]
Here is another: https://pubmed.ncbi.nlm.nih.gov/32574433/ [nih.gov]